Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progress in the study of the role of C5a-induced tubular cell senescence in the progression of diabetic kidney disease. | Ann Med | 2025 | 40970493 | PubTator, text mining | PubMed |
| Evaluating functional C1INH with multiple laboratory methods across Hereditary Angioedema types. | Front Immunol | 2025 | 40934007 | PubTator, text mining | PubMed |
| One-year real-life outcomes of lanadelumab therapy in Romanian patients with hereditary angioedema due to C1-inhibitor deficiency. | Front Allergy | 2025 | 40917874 | PubTator, text mining | PubMed |
| Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis. | Front Endocrinol (Lausanne) | 2025 | 40917351 | PubTator, text mining | PubMed |
| Insights From the First 820 Patients From the Brazilian Multicenter Registry of Hereditary Angioedema: The Key Role of Genetic Testing and Targeted Therapies. | J Allergy Clin Immunol Pract | 2025 | 40912615 | PubTator, text mining | PubMed |
| C1 inhibitor: from complement system to bradykinin angioedema. | Curr Opin Immunol | 2025 | 40907118 | PubTator, text mining | PubMed |
| Status quo and future developments in the diagnosis and treatment of hereditary angioedema. | J Dtsch Dermatol Ges | 2025 | 40905425 | PubTator, text mining | PubMed |
| Cross-Trait Meta-Analysis Reveals a Genetic Link between Inflammation and Aging in Giant Cell Arteritis. | Aging Dis | 2025 | 40901985 | PubTator, text mining | PubMed |
| Identification and validation of a tear fluid-derived protein biomarker signature in patients with amyotrophic lateral sclerosis. | Acta Neuropathol Commun | 2025 | 40898360 | PubTator, text mining | PubMed |
| Immune-coagulation dynamics in severe COVID-19 revealed by autoantibody profiling and multi-omics integration. | Sci Rep | 2025 | 40890263 | PubTator, text mining | PubMed |
| Garadacimab in hereditary angioedema due to normal C1INH with F12/PLG mutations. | J Allergy Clin Immunol | 2025 | 40876763 | PubTator, text mining | PubMed |
| Proteomic profiling identifies serpin G1, ApoA-II, and LBP as potential biomarkers of dementia in an Egyptian cohort. | Alzheimers Dement (Amst) | 2025 | 40861824 | PubTator, text mining | PubMed |
| The role of complement in long COVID pathogenesis. | JCI Insight | 2025 | 40857408 | PubTator, text mining | PubMed |
| Expanding the Genetic and Clinical Spectrum of Hereditary Angioedema with Normal C1 Inhibitor: Novel Variants and Treatment Insights. | J Clin Immunol | 2025 | 40848077 | PubTator, text mining | PubMed |
| A single-centre retrospective study on the clinical characteristics of patients with hereditary angioedema and the therapeutic effect of lanadelumab. | Orphanet J Rare Dis | 2025 | 40826407 | PubTator, text mining | PubMed |
| Pattern recognition receptor-associated immuno-thrombotic transcript changes in platelets and leukocytes with COVID19. | PLoS Pathog | 2025 | 40825056 | PubTator, text mining | PubMed |
| Increased contact system activity three months after starting combined oral contraceptives. | Thromb Res | 2025 | 40784181 | PubTator, text mining | PubMed |
| Disease control and disease activity in hereditary angioedema: two sides of the same coin? | Front Immunol | 2025 | 40766317 | PubTator, text mining | PubMed |
| Development and validation of a hypoxia-immune-based microenvironment gene signature for predicting survival in non-small cell lung cancer. | Discov Oncol | 2025 | 40759816 | PubTator, text mining | PubMed |
| 2024 CSACI Annual Scientific Meeting Book of Abstracts. | Allergy Asthma Clin Immunol | 2025 | 40745660 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=8